heartburn from semaglutide Can Give You Heartburn? Causes and Management Semaglutide and heartburn - Bmi

Data from a 2021 clinical trial published in the New England Journal of Medicine showed that tirzepatide led to patients losing more weight and experiencing a lesser degree of common side effects like nausea and diarrhea when compared to semaglutide, the active ingredient in Wegovy and Ozempic

As further clinical trials continue, it is anticipated that more drugs will be approved for use in people with obesity to support weight loss before often riskier interventions such as bariatric surgery are required

Added comments from neurologists and researchers about the trials findings.

Real-World Results: What Clinical Evidence Shows The SUSTAIN trial series (Novo Nordisk's registration studies) documented median weight loss of 9.3% at 68 weeks on maintenance semaglutideroughly 18-20 pounds for a 200-pound patient